Biomarker-driven management strategies for peripheral T cell lymphoma

Biomarker-driven management strategies for peripheral T cell lymphoma

Abstract Peripheral T cell lymphomas are heterogeneous diseases which remain treatment challenges. Recent advances in molecular and genomic profiling have provided unprecedented insight into disease pathogenesis driven by distinct cells of origins and molecular pathways. The discovery and clinical a...

Full description

Bibliographic Details
Main Authors: Erin Mulvey, Jia Ruan
Format: Article
Language:English
Published: BMC 2020-05-01
Series:Journal of Hematology & Oncology
Subjects:
CD30-positive peripheral T cell lymphoma (PTCL)
Nodal PTCL with T follicular helper (TFH) phenotype
Epigenetic targeting
HDAC inhibitors
Hypomethylating agents
Tumor microenvironment
Online Access:http://link.springer.com/article/10.1186/s13045-020-00889-z

Internet

http://link.springer.com/article/10.1186/s13045-020-00889-z

Similar Items